Grant: Discovery Grants Program - Individual
University of Saskatchewan
$28,000.00
Engineering functionalized diamond nanoparticles for intracellular delivery of nucleic acids
EF 2020-21
Résumé
The objective of my research program is to engineer novel nanomaterials that carry nucleic acids into mammalian cells. Gene delivery has been a significant research area for the past two decades, but the mainstream gene delivery nanomaterials, lipids and polymers pose limitations with respect to their stability, efficiency and toxicity. My research program focuses on the use of solid--core nanoparticles, such as nanodiamonds, to overcome these barriers. Nanodiamonds have a uniform size distribution and a large surface area available for chemical modifications. They are nontoxic in doses necessary for gene delivery. My research strategy is to chemically link amino acids to the nanodiamond in order to facilitate their interaction with nucleic acids. The novelty of this program lies in the approaches to the synthesis and characterization of nanoparticles conjugated with bioactive molecules, amino acids and elucidation of their beneficial and detrimental interactions with mammalian cells, organs and whole body.
The short--term research objectives build on my previous work: design of self--assembling lipid--based and diamond--based nanoparticles. To achieve our goal, we decorate the surface of nanodiamond with amino acids resulting in functionalized nanoparticles amenable to binding nucleic acids. We will assess the ability of these functionalized nanoparticles to deliver nucleic acids into model cells. The biodistribution of various functionalized nanodiamonds will be monitored. Relationships between structure/architecture delivery efficiency/toxicity will be established. This will lead to the selection of candidate vectors with optimal properties (improved binding properties, cellular uptake and high activity with no or minimal toxicity, and stability in biological environment) for delivering nucleic acids into cells.
To study the architecture of the delivery systems, high--resolution microscopy, flow cytometry and synchrotron-based techniques will be used. Correlating the surface properties of these nanoparticles with the delivery efficiency will allow for mapping universal and carrier--specific delivery mechanisms.
Long term, we will explore how the basic knowledge on chemical functionalization of the nanodiamond particles could be expanded to other solid--core and soft nanoparticles, establishing universal delivery principles for nucleic acids. Correlation of biodistribution to surface properties will be used as a model for predicting the biological fate of other man-made nanoparticles with similar surface properties. This research program will advance knowledge of the use and safety of the functionalized diamond--core nanoparticles as delivery systems for nucleic acids. Optimization of the characteristics of these delivery systems will benefit nanotechnology (a global market of $1.2B), eventually leading to gene therapy in humans and animals.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2020-05315
Name nom
Badea, Ildiko
Department département
College of Pharmacy and Nutrition
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
505
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Veterinary pharmaceuticals
Area of application fr
Produits pharmaceutiques à usage vétérinaire
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Installment
inst:1-5
Partie
5
Nb partie
5
Application title
Engineering functionalized diamond nanoparticles for intracellular delivery of nucleic acids
Keyword
NSERC
Application summary
The objective of my research program is to engineer novel nanomaterials that carry nucleic acids into mammalian cells. Gene delivery has been a significant research area for the past two decades, but the mainstream gene delivery nanomaterials, lipids and polymers pose limitations with respect to their stability, efficiency and toxicity. My research program focuses on the use of solid--core nanoparticles, such as nanodiamonds, to overcome these barriers. Nanodiamonds have a uniform size distribution and a large surface area available for chemical modifications. They are nontoxic in doses necessary for gene delivery. My research strategy is to chemically link amino acids to the nanodiamond in order to facilitate their interaction with nucleic acids. The novelty of this program lies in the approaches to the synthesis and characterization of nanoparticles conjugated with bioactive molecules, amino acids and elucidation of their beneficial and detrimental interactions with mammalian cells, organs and whole body.
The short--term research objectives build on my previous work: design of self--assembling lipid--based and diamond--based nanoparticles. To achieve our goal, we decorate the surface of nanodiamond with amino acids resulting in functionalized nanoparticles amenable to binding nucleic acids. We will assess the ability of these functionalized nanoparticles to deliver nucleic acids into model cells. The biodistribution of various functionalized nanodiamonds will be monitored. Relationships between structure/architecture delivery efficiency/toxicity will be established. This will lead to the selection of candidate vectors with optimal properties (improved binding properties, cellular uptake and high activity with no or minimal toxicity, and stability in biological environment) for delivering nucleic acids into cells.
To study the architecture of the delivery systems, high--resolution microscopy, flow cytometry and synchrotron-based techniques will be used. Correlating the surface properties of these nanoparticles with the delivery efficiency will allow for mapping universal and carrier--specific delivery mechanisms.
Long term, we will explore how the basic knowledge on chemical functionalization of the nanodiamond particles could be expanded to other solid--core and soft nanoparticles, establishing universal delivery principles for nucleic acids. Correlation of biodistribution to surface properties will be used as a model for predicting the biological fate of other man-made nanoparticles with similar surface properties. This research program will advance knowledge of the use and safety of the functionalized diamond--core nanoparticles as delivery systems for nucleic acids. Optimization of the characteristics of these delivery systems will benefit nanotechnology (a global market of $1.2B), eventually leading to gene therapy in humans and animals.